Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank creates NPF

6/24/24 SVCB

Arsagera started testing the Distributed analytics platform

6/21/24 ARSA

NCC converts client dollars and euros into roubles

6/21/24 MOEX

Launch of the second process line at Vysokoye mine is scheduled for July

6/21/24 UGLD

Number of trips per Whoosh user increased 32%

6/21/24 WUSH

Shareholders of Sberbank approved dividends for 2023

6/21/24 SBER

Yandex Go launched electric bicycle rental in Moscow

6/21/24 YDEX

China's Wison is leaving Russia

6/21/24 NVTK

Government determined the amount of Transneft dividends

6/21/24 TRNFP

Shareholders of Rosseti Centere approved dividends for 2023

6/20/24 MRKC